Changes in myocardial performance after administration of gallamine 1.5 mg kg" 1 and pancuronium 0.1 mg kg-1 were investigated in hypercapnic (.Paco, = 7.08 kPa) and hypocapnic CPaco, = 2.74 kPa) dogs anaesthetized with thiopentone, nitrous oxide and halothane. Administration of pancuronium during hypocapnia caused a decrease of 25% in dPjdc max (corrected for changes in preload, afterload and heart rate). This change was not seen during hypercapnia, probably because of the associated sympathetic stimulation. By contrast, gallamine was without effect on dP/dr max in both groups. The increase in heart rate and cardiac output caused by the atropine-like action of these relaxant drugs differed in the hypercapnic and hypocapnic group of dogs, with the more pronounced response in the latter group. The duration of the chronotropic changes was the same in both groups.
Studies of the circulatory changes after gallamine and pancuronium are usually made in the normocapnic or slightly hypocapnic state. The haemodynamic responses to changes in blood carbon dioxide concentration might modify those resulting from the drugs, just as changes in acid-base state might affect the haemodynamic action of gallamine and pancuronium by changing their pharmacological properties or the reactions at the receptor sites.
The aim of this study was to investigate the changes in myocardial performance in hypercapnic and hypocapnic experimental animals with regard to both the degree and the duration of alteration after administration of gallamine and pancuronium.
METHODS AND MATERIALS
Twenty healthy dogs (mean weight 20.9 (SEM2.1) kg) were studied.
Anaesthesia
Premedication consisted of morphine 1 mg kg" 1 i.m. Forty-five minutes later, thiopentone was given slowly i.v. until the eyelid reflexes disappeared (mean dose 15.1 mg kg-1 , SEM 0.5 mg kg-1 ). An endotracheal tube was inserted and anaesthesia was maintained with halothane 1% in a mixture of 25% oxygen in nitrous oxide. Mechanical ventilation was provided with an Elema-Schonander Servoventilator 900 set to provide an expiratory minute volume of approximately 400 ml kg" 1 , and a frequency of 20 b.p.m. The respiratory cycle was divided into three phases in the following proportion 25 : 10 : 65 for inspiration, inspiratory pause and expiration respectively. A constant inspiratory flow rate was used. The inspired oxygen concentration was controlled using an OHIO 200 oxygen monitor and the end-tidal carbon dioxide concentration using an infra-red analyser (Beckman medical gas analyser LB-2), sampled continuously from the proximal end of the tracheal tube. A heated humidifier was placed in the inspiratory limb of the ventilator tubing. A thermistor was placed in the oesophagus for continuous monitoring of temperature (Ellab M4-TEM), which was maintained in the range 36.0-37.0 °C (mean 36.8 °C, SEM 0.2 °C) using an insulating blanket and infrared radiation lamp placed above the exposed parts of the dog.
Cardiovascular measurements
The e.c.g. was recorded. Lignocaine 2% was used to infiltrate the inguinal region before dissection of the vessel. Catheters for measuring aortic and central venous pressure were passed through the right femoral artery and vein and positioned in the aortic arch and just outside the right atrium respectively, and were connected to Elema-Schonander EMT 34 pressure transducers. A micro-tip pressure transducer catheter (Millar PC-350A, Millar Instruments, U.S.A.) was positioned in the left ventricle by retrograde catherization of the left femoral artery. The left ventricular pressure signal was passed through a differentiator (accuracy 1% up to 75 Hz) to give the first derivative (dP/dt). Through the left femoral vein, a 110-cm triple lumen thermodilution catheter (ED SLAB model 93-122-7 F) was passed into the pulmonary artery under fluoroscopic control; it was connected to an integrating computer, which allowed electronic integration of the temperature-time curve (Hewlett Packard 130 cardiac output computer). The exact position of the catheter was confirmed by injection of radiological contrast medium. The central venous catheter was used as the injection route for myoneural blocking drugs and for the cold saline used in the thermodilution technique for measuring cardiac output.
The e.c.g., pressure curves and first derivative of the left ventricular pressure were all recorded on an eight-channel ink-jet recorder (Elema-Schonander EM 81). The mean aortic and central venous pressure were computed electronically.
Biochemical measurements
Arterial blood was analysed at each stage of the experiment; Pa 02 , Pa c02 and pH were measured using a Radiometer ABL 1. Corrections were applied for temperature differences, using a Radiometer blood-gas calculator. The same calculator was used to determine base excess from Pa^, pH and haemoglobin concentration, which in turn was determined by a cyanmethaemoglobin technique.
Computations
Cardiac output was determined by the thermodilution method (Branthwaite and Bradley, 1968; Forrester et al., 1972) and was calculated from the values of initial blood temperature, initial injectate temperature and the integral of the blood temperaturetime curve by using a program for the HewlettPackard 9821A desk computer. Stroke volume was calculated from cardiac output and R-R intervals from the e.c.g. Stroke volume and cardiac output were expressed as "normalized" values (ml kg-1 body weight). Systemic vascular resistance was calculated using the formula: mean aortic pressure cardiac output x8()>< 1Q _ 4 _ ŵ here aortic pressure is mm Hg and cardiac output litre min"
1 . The maximum rate of increase of left ventricular pressure (dP/d/max) is known to be affected by changes in preload (left ventricular end diastolic pressure (LVEDP)), afterload (systolic pressure) and heart rate, and by changes in the inotropic state (Wallace, Skinner and Mitchell, 1963; Mason et al., 1972) .
In a recent study in our laboratory (Videbaek, 1976 ) the statistical interrelationship between indices derived from ventricular pressure measurements on the one hand and heart rate, LVEDP and arterial systolic pressure on the other, was investigated. The design of the experiment was similar to the present study, although a barbiturate was used as the anaesthetic. By means of multivariate statistical analysis, a regression was found between dPjdt max and the haemodynamic parameters mentioned above:
Log dP/dt max = -0.7604 log RR + 0.1124 log LVEDP + 0.2446 log systolic pressure + 11.0384
All partial regression coefficients were statistically different from zero (P<0.01 for all). By using this equation it is possible to compensate for changes in afterload and preload during the experiment and to evaulate the changes in dP/d*max induced by alteration of heart rate. In this paper the term dP/dt max corr is used for dPjdt max, when this figure is corrected for changes in LVEDP, systolic pressure and heart rate following the above regression.
Experimental protocol
The dogs were allocated randomly to one of four groups (hypocapnia-pancuronium, hypercapnia-pancuronium, hypocapnia-gallamine, hypercapnia-gallamine), each group consisting of five animals. In all groups, the volume of ventilation was set to achieve a "primary" arterial carbon dioxide tension of approximately 2.66 kPa. Blood-gas analysis was performed as soon as the arterial catheter was positioned, but always after at least 30 min of constant ventilation. In the hypocapnic groups this ventilation was continued. In the hypercapnic groups carbon dioxide was added to the inspiratory mixture in order to achieve -Pa COa of approximately 7.32 kPa. When this was reached, 30 min was allowed to enable the cardiovascular state to stabilize. To avoid the depressant effects of extreme metabolic acidosis, the base deficit was adjusted so that it did not exceed a value of 5 mmol litre" 1 by infusion of small volumes of sodium bicarbonate 8.4%. The relaxant drugs were administered at about 2 h after induction of anaesthesia (mean 127 min, SEM6min); pancuronium was given in a dose of 0.1 mg kg" 1 , gallamine in a dose of 1.5 mg kg -1 body weight.
Control measurements of myocardial performance were obtained just before administration of the drugs, and at 1, 2, 3, 5,10,15, 20,25 and 30 and at each 10 min thereafter. Records were taken with ventilation stopped (airway pressure 0 cm H 2 O; lung volume at functional residual capacity). Determinations of cardiac output were made in duplicate at each stage. The reaction to a second dose of relaxant was recorded 140 min after administration of the first dose.
Statistical analysis
The measured myocardial performance variables were compared with control measurements and the deviations expressed as per cent, taking controls as 100%. In each group the method of paired comparisons was used to describe the differences (two-tailed test). From one group to another the Student's t test for unpaired data (two-tailed) was used to evaluate the differences. P<0.05 was taken as a statistically significant difference.
RESULTS

Control
The differences in blood-gases and acid-base state between the hypercapnic and hypocapnic groups are shown in table I. Table II shows haemodynamic variables in the two different basal conditions. There were statistically significant differences in central venous pressure, LVEDP and systemic vascular resistance (SVR) between the two groups, but not in heart rate, mean aortic pressure, normalized cardiac output, normalized stroke volume and dP/dtmax, although the values were greater in the hypercapnic group. 
Gallamine
The administration of gallamine significantly increased heart rate from control value for the first 60 min in both groups (7 3 <0.05) ( fig. 1 ), but with a slightly more pronounced response in the hypocapnic group. Normalized cardiac output increased to values which differed significantly from control for the first 30 min (/ 5 <0.05). The difference in cardiac output between the hypocapnic and hypercapnic group was statistically significant only in the 1st and 5th min (P<0.05). The observations for stroke volume follow the same pattern, but are not significantly different from the control values.
A small, although not statistically significant, decrease in LVEDP was recorded just before the reduction in cardiac output in the hypocapnic group at the 3rd min. In the hypercapnic group a decrease in LVEDP during the experiments was recorded (from 11 to 8 mm Hg, P<0.05).
Mean aortic pressure, central venous pressure, systemic vascular resistance and dP/dt max corr were unaltered during the investigations. The corrected and uncorrected values for dP/dt max are given in table III. There was no difference in the duration of the cardiovascular changes between the two groups. The second dose evoked similar, although smaller, changes, of shorter duration.
Pancuronium
A statistically significant increase in heart rate from control values was recorded for the first 20 min in both groups CP<0.05) ( fig. 2 ), but with a more pronounced response in the hypocapnic group. The difference between the two groups was statistically significant only at 2 min after the injection (P < 0.05).
The normalized cardiac output changed in a manner similar to that of the control, but the difference was significant only in the first 10 min (P< 0.05). No difference in cardiac output between the groups could be detected.
Normalized stroke volume and mean aortic pressure were unchanged during the experiments. Central venous pressure and LVEDP did not change in the hypocapnic dogs, but a reduction from the control value was recorded in the hypercapnic dogs (LVEDP from llmmHg to 8mmHg, P<0.05; central venous pressure from 10 mm Hg to 7 mm Hg, P<0.05).
Systemic vascular resistance decreased from the control value in both groups, but especially in the hypocapnic group, where the reduction was found to be statistically significant for the first 10 min (P<0.05). No significant difference was found between the two groups.
A significant reduction from the control value was recorded in respect ofdPjdt max corr in the hypocapnic group (P<0.05), lasting from the 3rd to the 25th min. The values in the hypercapnic group were unaltered during the investigation. The uncorrected and corrected values for dPjdt max are listed in table IV. The duration of the cardiovascular changes was the same in the two groups. Administration of a second dose was followed by less pronounced changes of shorter duration, but with the same trends. 
Carbon dioxide
Changes in arterial carbon dioxide tension are followed by changes in sympatho-adrenal activity. This response is evoked by stimulation or inhibition of centres in the hypothalamic region and is mediated through changes in catecholamine secretion (Sechzer et al., 1960; Cross and Silver, 1962) . Accumulation of carbon dioxide induces an increase in cardiac output, heart rate and indices of myocardial contractility, while systemic vascular resistance decreases. Carbon dioxide washout leads to changes in the opposite direction Cullen and Eger 1974) . Cardiovascular changes evoked by carbon dioxide accumulation during anaesthesia are modified by different anaesthetics to a variable extent (Price et al., 1959) . Haemodynamic responses to hypocapnia and hypercapnia during halothane anaesthesia have been determined by various investigators (Theye, Milde and Michenfelder, 1966; Prys-Roberts et al., 1967; Foex and Prys-Roberts, 1975) . Changes occurred in cardiac output (augmented by hypercapnia) and systemic vascular resistance (augmented by hypocapnia) without modification of the contractile state of myocardium and without significant changes in heart rate, filling pressures or aortic pressure. Changes in stroke volume were found to parallel the changes in cardiac output. The factors governing alteration in cardiac output were changes in afterload and sympathetic activity (Foex and Prys-Roberts, 1975) .
Our results confirm these findings with one exception. The increased filling pressures in hypercapnia indicate that changes in preload contributed to the increase in cardiac output.
Atropine-like action
Cardiovascular changes elicited by pancuronium and gallamine have been studied by many investigators. The use of these drugs in man is often followed by an increase in heart rate leading to an increase in cardiac output, although modified by the chosen anaesthetic and premedicant. Small increases in arterial pressure accompanied by decreases in central venous pressure occur. Stroke volume varies to only a minor degree. Systemic vascular resistance decreases after the injection of gallamine but not after pancuronium (Smith and Whitcher, 1967; Kennedy and Farman, 1968; Kelman and Kennedy, 1971; Coleman et al., 1972; Stoelting, 1972 Stoelting, , 1973 . In experiments using isolated organ perfusion, both pancuronium and gallamine produced a blockade of the muscarinic receptors of the heart, resulting in an increase in heart rate (Rathburn and Hamilton, 1970; Saxena and Bonta, 1970; Goat and Feldman, 1972; Duke, Fung and Gartner, 1975) .
The increase in cardiac output after the injection of pancuronium and gallamine in our study was a result of changes in heart rate, as no alterations in stroke volume occurred. The small and inconsistent differences in percentage increase in heart rate and cardiac output between the hypocapnic and hypercapnic groups can be explained by the differences in heart rate in the control state. It has been shown that a negative correlation exists between heart rate before administration of pancuronium and maximum increase in heart rate, and that previous administration of atropine inhibits the tachycardia seen after gallamine and pancuronium (Coleman et al., 1972; Reitan, Fraser and Eisele, 1973; Miller et al., 1975) . The changes in systemic vascular resistance are parallel to the changes in cardiac output. As ganglionic transmission in the sympathetic nervous system is affected only slightly after pancuronium and gallamine (Buckets' et al., 1968; Hughes and Chappie, 1976) , it might be concluded that the changes in resistance were induced reflexly and secondary to the increase in cardiac output. Brown and Crout (1970) found that administration of gallamine increased the contractile force of guineapig and cat atria in vitro; similarly, they found increases in contractile force in the anaesthetized open-chest cat. Previous administration of propranolol inhibited these responses. It was suggested, therefore, that gallamine released noradrenaline from adrenergic nerve endings in the heart. In contrast to this, a study in man during open heart surgery using a Walton-Brodie strain-gauge arch failed to demonstrate any change in myocardial contractile force associated with administration of gallamine (Longnecker, Stoelting and Morrow, 1973) . Furthermore, a study using systolic time intervals demonstrated that no positive inotropic action resulted from the administration of gallamine in human subjects anaesthetized with halothane (Reitan, Fraser and Eisele, 1973) . Matsuki, Kothary and Zsigmond (1973) found, after gallamine in man, a small, but significant increase in the concentration of free noradrenaUne in plasma during halothane anaesthesia, whereas no alteration in free plasma adrenaline was found.
Gallamine and the inotropic state
We were not able to demonstrate any change in dP/dt max corrected for changes in heart rate, LVEDP and systolic pressure in our experiment and we must conclude, therefore, that administration of gallamine is not followed by any positive inotropic response during nitrous oxide-halothane anaesthesia.
Pancuronium and the inotropic state
It has been suggested that pancuronium does possess catecholamine releasing properties (Loh, 1970) . However, a study using rabbit atrial strips and cat papillary muscle failed to reveal any change in contractile force after exposure to pancuronium (Duke, Fung and Gartner, 1975) .
The results of blood catecholamine determination after pancuronium are conflicting. In one study, a significant increase in the concentration of both adrenaline and noradrenaline in plasma was recorded after pancuronium during halothane anaesthesia (Aurel, Cardan and Domokos, 1973) . In other investigations no alterations were demonstrated during either nitrous oxide-oxygen-fentanyl or thiamylalnitrous oxide-oxygen anaesthesia (Takki and Tammisto, 1973; Zsigmond et al., 1974) .
Our results show that administration of pancuronium is followed by a 25% decrease in dPjdt max corr , when the drug is administered during hypocapnia, whereas no changes are detectable during hypercapnia. This negative inotropic action is seldom, if ever, recognized in clinical practice, because of the compensating effect of the positive chronotropic action of the drug. In our study, no increase in filling pressure or alteration in stroke volume was encountered during hypocapnia. Furthermore, it is demonstrated that the uncorrected dP/dt max values changed only to a minor extent from the control values. However, the possibility exists that administration of pancuronium to the hyperventilated patient with conduction disturbances (A-V block), treatment with (3-blockers or cardiac decompensation might disclose this effect and induce signs of pump faliure, but further human studies are needed to elucidate this point. The difference seen between the hypercapnic and hypocapnic groups can probably be explained by the supportative action of the increased sympathetic activity which exists in the hypercapnic state.
Acid-base state
It is well known that changes in acid-base state affect the neuromuscular blocking action of gallamine (prolonged block associated with alkalosis) and pancuronium (acidosis reducing rate of recovery) (Baraka, 1967; Walts, Lebowitz and Dillon, 1967; Katz and Seed, 1970) . This difference in duration of action has been related to changes in drug-protein binding and to changes in cholinesterase activity. Altered ionization of the relaxant molecule can be ruled out as an explanation of the different effects because the pKa values of both drugs are greater than 13 (Baraka, 1967; Dann, 1971) . We found no differences in the duration of the cardiovascular changes elicited by either drug in the hypercapnic or hypocapnic state, although the possibility remains that separating the pH values by more than 0.29 units might have revealed some disparity, but this seems to be a question of academic interest only.
Second dose
Changes evoked by a second dose of relaxant are predictably of lesser degree and duration, and this was confirmed in our study. Although the control state before administering the second dose resembled the state just before administration of the first dose, the cardiac receptors must be partially occupied, resulting in only minor changes in the cardiovascular variables.
VARIATIONS DES PERFORMANCES MYOCARDIAQUES PROVOQUEES PAR LE PANCURONIUM ET LA GALLAMINE SUR DES CHIENS HYPERCAPNIQUES ET HYPOCAPNIQUES
RESUME
On a etudie les variations des performances myocardiaques apres administration de gallamine (1,5 mg/kg) et de pancuronium (0,1 mg/kg) a des chiens hypercapniques (Pa C o, = 7,08 kPa) et hypocapniques (Pa C0] = 2,74 kPa) anesthesies a l'aide de thiopentone, de protoxyde d'azote et d'halothane. L'administration de pancuronium pendant l'hypocapnie a provoque une diminution de 25% de la dPjdt maximale (corrigee pour variations dans le prechargement, le postchargement et la frequence cardiaque). Cette variation n'a pas ete constatee pendant l'hypercapnie, probablement en raison de la stimulation sympathique qui lui est associee. Par contre, la gallamine est restee sans effet sur la dPjdt maximale dans les deux groupes. L'augmentation de la frequence et du debit cardiaques causee par Paction semblable a celle de l'atropine de ces deux agents decontracturants a differe dans les deux groupes de chiens (hypercapniques et hypocapniques), la reaction la plus prononcee se produisant dans ce dernier groupe. La duree des variations chronotropiques a ete la meme dans les deux groupes.
VON PANKURONIUM UND GALLAMIN VERURSACHTE ANDERUNGEN DER MYOKARDLEISTUNG IN HYPERKAPNISCHEN UND HYPOKAPNISCHEN HUNDEN
ZUSAMMENFASSUNG
Anderungen der Myokardleistung nach Eingebung von Gallamin (1,5 mg/kg" 1 ) und Pankuronium (0,1 mg/kg-1 ) wurden in hyperkapnischen (Pa co , = 7,08 kPa) und hypokapnischen (Pac 0 , = 2,74 kPa) Hunden untersucht, die mit Thiopenton, Stickoxydul und Halothan betaubt worden waren. Die Eingebung von Pankuronium wahrend der Hypokapnie verursachte eine 25%ge Erniedrigung des max. dPjdt (nach Beriicksichtigung der Anderungen der Vorlast, der Nachlast und des Pulses). Eine solche Anderung war wahrend der Hyperkapnie nicht zu bemerken, wahrscheinlich wegen der begleitenden sympathischen Anreizung. Andererseits hatte Gallamin keine Wirkung auf das max. dPjdt in beiden Gruppen. In der von der atropinartigen Wirkung dieser Entspannungsmittel verursachten Steigerung der Pulses und der Herzleistung unterschied sich die hyperkapnische von der hypokapnischen Hundegruppe; die deutlichere Reaktion war in den hypokapnischen Hunden zu sehen. Die Dauer der chronotropischen Anderungen war in beiden Gruppen gleich.
CAMBIOS EN EL RENDIMIENTO MIOCARDIACO INDUCIDOS POR PANCURONIO Y GALAMINA EN PERROS HIPERCAPNICOS E HIPOCAPNICOS
SUMARIO
Se investigaron cambios en el rendimiento miocardiaco despues del suministro de galamina 1,5 mg kg-1 y .pancuronio 0,lmgkg-1 en perros hipercapnicos (,Pa-co t = 7,08 kPa) e hipocapnicos (Paco, = 2,74kPa), anestesiados con tiopentona, oxido nitroso y halotano. La administraci6n de pancuronio durante hipocapnia produjo una disminuci6n de un 25% en dPIdt max (corregido para cambios de precarga, carga posterior y velocidad del corazdn). Este cambio no fue notado durante hipercapnia, posiblemente debido al estimulo de simpatia asociado. En cambio, la galamina no ejercio efecto alguno sobre dPjdt max en ambos grupos. El aumento de la velocidad del coraz6n y capacidad cardiaca causado por la acci6n atropinica de estas drogas relajantes difirid entre el grupo hipercapnico e hipocapnico de perros, produciendose respuestas mas pronunciadas en el ultimo grupo. La duraci6n de los cambios cronotropicos resulto igual en ambos grupos.
